Company intelligence / Profile preview

Disetronic Medical Systems

Burgdorf, Bern, Switzerland

Ownership: Private
Development stage: Other

Overview

Disetronic Medical Systems is a pioneering medical technology company specializing in the development and manufacture of insulin delivery systems for the treatment of diabetes. Founded in Switzerland, the company became a global leader in the insulin pump market with its H-TRON and D-TRON product lines. In 2003, Disetronic was acquired by Roche, where its technology was integrated into the Accu-Chek brand of diabetes management products. Today, the company's legacy continues through Roche Diabetes Care, providing advanced infusion pumps and digital health solutions to patients worldwide.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Disetronic Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Disetronic Medical Systems.

Explore the full profile